Piper Sandler Starts Sykes Enterprises (SKYE) at Overweight, 'Nimacimab Validated Obesity Drug'
Tweet Send to a Friend
(Updated - February 5, 2024 3:56 AM EST)
Piper Sandler analyst Edward Tenthoff initiates coverage on Sykes Enterprises (OTC ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Piper Sandler analyst Edward Tenthoff initiates coverage on Sykes Enterprises (OTC ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
